"Designing Growth Strategies is in our DNA"
Clinical chemistry, also known as medical or clinical biochemistry, is a rapidly developing industry operating across the globe. It is a part of clinical pathology that is usually apprehensive with analysis of body fluids for therapeutic and diagnostic purposes. Some of the most common body fluids tested in clinical chemistry include blood and urine. Components may include blood glucose, enzymes, electrolytes, hormones, lipids (fats), other metabolic substances, and proteins. Clinical chemistry tests include general tests, special tests (electrophoresis), clinical endocrinology tests, diagnostic tests, toxicology tests, and urinalysis. Clinical chemistry for enzymes often provides information regarding the occurrence of diseases such as pancreatic cancer or damage to organs in the body. Clinical chemistry also includes tests which function as cardiac markers and tumor markers for detection of cardiac and cancer disorders. The global clinical chemistry market is anticipated to considerably and substantially grow, owing to several factors. The American Diabetes Association (ADA) estimated that in the U.S., every year about 1.5 million individuals are diagnosed with diabetes and in the year 2015, 30.3 million Americans, i.e., 9.4% of the population had diabetes. ADA also estimated that in the geriatric population, the rate of diabetes incidence is higher, affecting about 25.2%, i.e., 12 million of the seniors annually. According to the American Cancer Society, in the U.S, 1,688,780 new cancer cases were diagnosed, and 600,920 cancer deaths occurred in 2017. For most of these diseases, clinical chemistry is the first line of diagnosis and start of treatment, carried out through blood tests.
Increased prevalence of infectious and chronic diseases such as cancers and diabetes, which lead to a demand for swift and accurate diagnosis is responsible for driving the clinical chemistry market during the forecast period. Unhealthy diet, sedentary lifestyle, and lack of exercise leading to lifestyle disorders are also the factors driving the clinical chemistry market. Increasing technological advancements coupled with other factors such as increasing disposable incomes leading to greater demand for advanced diagnostics and the life-threatening nature of the diseases/ disorders are also fueling the market growth.
To gain extensive insights into the market, Request for Customization
However, the absence of skilled professionals to conduct clinical chemistry tests is responsible for inhibiting the growth of the clinical chemistry market. Another factor that limits the growth of the market is the associated high cost of the clinical chemistry test, which is a key disadvantage, especially in the emerging markets.
Some of the major companies that are present in the global clinical chemistry market are Abbott, F. Hoffmann-La Roche Ltd, ELITechGroup, Beckman Coulter, Inc., Thermo Fisher Scientific, Alfa Wassermann Inc., Ortho-Clinical Diagnostics, Diatron, Nova Biomedical, and other players.
By Product Type
· Reagents & Consumables
· General Chemistry Test (Basic metabolites panel)
· Liver Function Test
· Kidney Function Test
· Electrolyte Panel
· Lipid Profile
· Specialty Chemical Test
By End User
· Diagnostic/Pathology Centers
· Ambulatory Surgery Centers (ASC)
· North America (U.S and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico, and Rest of Latin America)
· Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)
Among the product segment, analyzers account for the largest proportion of the market because it is one of the primary and first line products used in the clinical chemistry market. Also, it is used to conduct the majority of clinical chemistry tests.
The global clinical chemistry market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for the largest share of the clinical chemistry market owing to the presence of the highly developed healthcare facilities, ongoing R&D initiatives combined with the increasing prevalence of acute and chronic diseases, and focus on healthy living. Europe is also anticipated to register significant growth during the forecast period owing to its growing healthcare infrastructures, adoption of automated clinical chemistry analyzers, and high diabetes, blood pressure, lung and heart diseases patient pool. In the Asia Pacific region, Japan, along with China and India, is expected to provide the largest market opportunity. This is because Japan has a highly developed healthcare and insurance facilitiesChina and India are anticipated to be the fastest emerging markets owing to the rising prevalence of lifestyle-related disorders.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry